Rhythm Pharmaceuticals In... (RYTM)
54.80
1.31 (2.45%)
At close: Mar 28, 2025, 3:59 PM
54.80
0.01%
After-hours: Mar 28, 2025, 04:33 PM EDT
Rhythm Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 130.13M | 77.43M | 23.64M | 3.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 13.37M | 9.3M | 2.13M | 599K | 690K | 834K | 442K | 223K | 144K | n/a | n/a | n/a | n/a |
| Gross Profit | 116.76M | 68.13M | 21.5M | 2.56M | -690K | -834K | -442K | -223K | -144K | n/a | n/a | n/a | n/a |
| Operating Income | -265.5M | -184.36M | -179.16M | -170.06M | -136.57M | -146M | -78.42M | -32.41M | -25.91M | -10.57M | -6.49M | -21.45M | -18.14M |
| Interest Income | 14.71M | 13.95M | 4.03M | 447K | 2.58M | 5.27M | 4.35M | 566K | 33K | n/a | n/a | n/a | n/a |
| Pretax Income | -260.26M | -184.11M | -181.12M | -69.61M | -134M | -140.73M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Net Income | -260.6M | -184.68M | -183.08M | -68.01M | -130.73M | -134.62M | -74.06M | -33.71M | -25.87M | -11.07M | -6.49M | -21.43M | -18.13M |
| Selling & General & Admin | 144.3M | 117.53M | 92.03M | 68.49M | 46.13M | 36.55M | 28.08M | 9.52M | 6.31M | 3.42M | 1.21M | 3.43M | 2.46M |
| Research & Development | 237.96M | 134.95M | 108.63M | 104.13M | 90.45M | 109.45M | 50.34M | 22.89M | 19.59M | 7.15M | 5.28M | 18.02M | 15.68M |
| Other Expenses | n/a | n/a | -790K | 100M | n/a | n/a | n/a | -1.86M | n/a | -500K | n/a | n/a | n/a |
| Operating Expenses | 382.26M | 252.48M | 200.66M | 172.61M | 136.57M | 146M | 78.42M | 32.41M | 25.91M | 10.57M | 6.49M | 21.45M | 18.14M |
| Interest Expense | 20.6M | 13.89M | 5.2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 395.63M | 261.79M | 202.79M | 173.21M | 136.57M | 146M | 78.42M | 32.41M | 25.91M | 10.57M | 6.49M | 21.45M | 18.14M |
| Income Tax | 346K | 564K | 1.96M | -1.6M | -3.27M | -6.11M | 4.35M | 1.07M | n/a | n/a | n/a | n/a | n/a |
| Shares Outstanding (Basic) | 61M | 57.67M | 52.12M | 49.6M | 44.13M | 36.42M | 31M | 13.27M | 16.73M | 16.73M | 10.2M | 50.27M | 50.27M |
| Shares Outstanding (Diluted) | 61M | 57.67M | 52.12M | 49.6M | 44.13M | 36.42M | 31M | 13.27M | 16.73M | 16.73M | 10.2M | 50.27M | 50.27M |
| EPS (Basic) | -4.21 | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 | -0.43 | -0.36 |
| EPS (Diluted) | -4.21 | -3.2 | -3.51 | -1.37 | -2.96 | -3.7 | -2.39 | -2.54 | -1.55 | -0.66 | -0.64 | -0.43 | -0.36 |
| EBITDA | -238.09M | -168.46M | -174.51M | -68.45M | -135.88M | -145.17M | -77.97M | -32.19M | -25.76M | -10.07M | n/a | -21.41M | -18.12M |
| Depreciation & Amortization | 1.56M | 1.76M | 1.4M | 1.16M | 690K | 834K | 442K | 223K | 144K | 500K | 6.49M | 20K | 17K |